Sign in
ADTX Stock Price, Chart, Stats & News
Aditxt, Inc.
Save
Aditxt, Inc. (ADTX) does not currently pay a dividend.
2.99M
Market cap
–
Current P/E
–
Forward P/E
ADTX chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques. The company's developments include AditxtScore, a platform designed to empower individuals by providing insights into their immune profiles for better management and informed awareness of immune system attacks or dysfunctions. Aditxt also pioneers Apoptotic DNA Immunotherapy, a nucleic acid-based solution that emulates the body's inherent mechanisms for developing self-tolerance to its own tissues.
Similar securities
Based on sector and market capitalization
Report issue